Patent · US Active

Compounds

US8399481B2 · kind B2 · utility

0Cited by
4References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 4, 2010
Grant dateMar 19, 2013
Priority date—
Expiry dateNov 26, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of formula (I)Or its salts or pharmaceutically acceptable derivatives thereof wherein;

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.